Celcuity Inc. (CELC) Financials
CELC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 828.2 million | 841.0 million |
| March 31, 2026 | 410.2 million | 356.6 million |
| Dec. 31, 2025 | 466.6 million | 366.0 million |
| Sept. 30, 2025 | 476.0 million | 359.0 million |
CELC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -55.5 million | 6.9 million |
| March 31, 2026 | -55.3 million | 5.3 million |
| Dec. 31, 2025 | -36.5 million | 9.5 million |
| Sept. 30, 2025 | -44.9 million | 6.8 million |
CELC Net Income
No data available :(
CELC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 182.0 million | 754.1 million | - |
| March 31, 2026 | 145.2 million | 195.6 million | 13000 |
| Dec. 31, 2025 | 441.5 million | 195.3 million | 54000 |
| Sept. 30, 2025 | 455.0 million | 320.2 million | 96000 |
CELC Shares Outstanding
CELC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 51000 | 31.1 million | 35.0 million | - |
| March 31, 2026 | 249000 | 33.1 million | 17.4 million | - |
| Dec. 31, 2025 | 53000 | 37.6 million | 11.6 million | - |
| Sept. 30, 2025 | 97000 | 34.9 million | 7.9 million | - |
CELC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 47000 |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | 154000 | 41000 |
CELC
Price: $92
52 week price:
Earnings Per Share: -4.30 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 28600
Market Capitalization: 4.5 billion